AN ADRENAL ADENOMA CAUSING VIRILIZATION OF MOTHER AND INFANT

P. J. Fuller, I. G. Pettigrew, J. W. Pike, J. R. Stockigt

Research output: Contribution to journalArticleResearchpeer-review

17 Citations (Scopus)

Abstract

A right adrenal androgen‐producing adenoma was identified by CT scanning in a 33‐year‐old woman after delivery of an otherwise‐normal, virilized female infant. Despite clinical evidence of mild chronic androgen excess, maternal reproductive function was normal. Post‐partum studies showed 2–5‐fold excess in maternal plasma testosterone, androstenedione and dehydroepiandrosterone‐sulphate; urinary androgen metabolites were increased 3–10‐fold. Androgen production from the tumour increased acutely in response to hCG administration; after removal of the tumour, androgen levels were normal and showed negligible responses to hCG. These findings lead us to speculate that endogenous chorionic gonadotrophin may have led to augmented androgen production from the adrenal tumour during pregnancy, causing fetal virilization as previously described in patients with ovarian tumours. This study demonstrates that CT scanning can be valuable in distinguishing between adrenal and ovarian androgen‐producing tumours, a distinction which is often unreliable when based on physiological manipulations of hormone secretion.

Original languageEnglish
Pages (from-to)143-153
Number of pages11
JournalClinical Endocrinology
Volume18
Issue number2
DOIs
Publication statusPublished - 1983

Cite this

Fuller, P. J. ; Pettigrew, I. G. ; Pike, J. W. ; Stockigt, J. R. / AN ADRENAL ADENOMA CAUSING VIRILIZATION OF MOTHER AND INFANT. In: Clinical Endocrinology. 1983 ; Vol. 18, No. 2. pp. 143-153.
@article{ba4e527fb4b443539d12d247604fbede,
title = "AN ADRENAL ADENOMA CAUSING VIRILIZATION OF MOTHER AND INFANT",
abstract = "A right adrenal androgen‐producing adenoma was identified by CT scanning in a 33‐year‐old woman after delivery of an otherwise‐normal, virilized female infant. Despite clinical evidence of mild chronic androgen excess, maternal reproductive function was normal. Post‐partum studies showed 2–5‐fold excess in maternal plasma testosterone, androstenedione and dehydroepiandrosterone‐sulphate; urinary androgen metabolites were increased 3–10‐fold. Androgen production from the tumour increased acutely in response to hCG administration; after removal of the tumour, androgen levels were normal and showed negligible responses to hCG. These findings lead us to speculate that endogenous chorionic gonadotrophin may have led to augmented androgen production from the adrenal tumour during pregnancy, causing fetal virilization as previously described in patients with ovarian tumours. This study demonstrates that CT scanning can be valuable in distinguishing between adrenal and ovarian androgen‐producing tumours, a distinction which is often unreliable when based on physiological manipulations of hormone secretion.",
author = "Fuller, {P. J.} and Pettigrew, {I. G.} and Pike, {J. W.} and Stockigt, {J. R.}",
year = "1983",
doi = "10.1111/j.1365-2265.1983.tb03197.x",
language = "English",
volume = "18",
pages = "143--153",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "2",

}

AN ADRENAL ADENOMA CAUSING VIRILIZATION OF MOTHER AND INFANT. / Fuller, P. J.; Pettigrew, I. G.; Pike, J. W.; Stockigt, J. R.

In: Clinical Endocrinology, Vol. 18, No. 2, 1983, p. 143-153.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - AN ADRENAL ADENOMA CAUSING VIRILIZATION OF MOTHER AND INFANT

AU - Fuller, P. J.

AU - Pettigrew, I. G.

AU - Pike, J. W.

AU - Stockigt, J. R.

PY - 1983

Y1 - 1983

N2 - A right adrenal androgen‐producing adenoma was identified by CT scanning in a 33‐year‐old woman after delivery of an otherwise‐normal, virilized female infant. Despite clinical evidence of mild chronic androgen excess, maternal reproductive function was normal. Post‐partum studies showed 2–5‐fold excess in maternal plasma testosterone, androstenedione and dehydroepiandrosterone‐sulphate; urinary androgen metabolites were increased 3–10‐fold. Androgen production from the tumour increased acutely in response to hCG administration; after removal of the tumour, androgen levels were normal and showed negligible responses to hCG. These findings lead us to speculate that endogenous chorionic gonadotrophin may have led to augmented androgen production from the adrenal tumour during pregnancy, causing fetal virilization as previously described in patients with ovarian tumours. This study demonstrates that CT scanning can be valuable in distinguishing between adrenal and ovarian androgen‐producing tumours, a distinction which is often unreliable when based on physiological manipulations of hormone secretion.

AB - A right adrenal androgen‐producing adenoma was identified by CT scanning in a 33‐year‐old woman after delivery of an otherwise‐normal, virilized female infant. Despite clinical evidence of mild chronic androgen excess, maternal reproductive function was normal. Post‐partum studies showed 2–5‐fold excess in maternal plasma testosterone, androstenedione and dehydroepiandrosterone‐sulphate; urinary androgen metabolites were increased 3–10‐fold. Androgen production from the tumour increased acutely in response to hCG administration; after removal of the tumour, androgen levels were normal and showed negligible responses to hCG. These findings lead us to speculate that endogenous chorionic gonadotrophin may have led to augmented androgen production from the adrenal tumour during pregnancy, causing fetal virilization as previously described in patients with ovarian tumours. This study demonstrates that CT scanning can be valuable in distinguishing between adrenal and ovarian androgen‐producing tumours, a distinction which is often unreliable when based on physiological manipulations of hormone secretion.

UR - http://www.scopus.com/inward/record.url?scp=0020659967&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2265.1983.tb03197.x

DO - 10.1111/j.1365-2265.1983.tb03197.x

M3 - Article

VL - 18

SP - 143

EP - 153

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 2

ER -